BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1143 related articles for article (PubMed ID: 30590238)

  • 1. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.
    Titulaer MJ; Höftberger R; Iizuka T; Leypoldt F; McCracken L; Cellucci T; Benson LA; Shu H; Irioka T; Hirano M; Singh G; Cobo Calvo A; Kaida K; Morales PS; Wirtz PW; Yamamoto T; Reindl M; Rosenfeld MR; Graus F; Saiz A; Dalmau J
    Ann Neurol; 2014 Mar; 75(3):411-28. PubMed ID: 24700511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
    Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
    J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
    Nagata S; Nishimura Y; Mitsuo K
    Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral cortical encephalitis followed by recurrent CNS demyelination in a patient with concomitant anti-MOG and anti-NMDA receptor antibodies.
    Zhou L; ZhangBao J; Li H; Li X; Huang Y; Wang M; Zhao C; Lu J; Lu C; Li Y; Quan C
    Mult Scler Relat Disord; 2017 Nov; 18():90-92. PubMed ID: 29141829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
    Pérez CA; Agyei P; Gogia B; Harrison R; Samudralwar R
    J Neuroimmunol; 2020 Feb; 339():577124. PubMed ID: 31837635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies.
    Rojc B; Podnar B; Graus F
    J Neuroimmunol; 2019 Mar; 328():86-88. PubMed ID: 30599296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report.
    Cao L; Ren L; Huang X
    Medicine (Baltimore); 2021 Jan; 100(1):e24234. PubMed ID: 33429822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.
    Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C
    Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Anti-
    Zhang S; Yang Y; Liu W; Li Z; Li J; Zhou D
    Front Immunol; 2022; 13():857443. PubMed ID: 35837405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
    Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
    Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated anti-N-methyl-D-aspartate receptor encephalitis coexisting with anti-myelin oligodendrocyte glycoprotein antibody-associated diseases: A case report.
    Aoe S; Kokudo Y; Takata T; Kobara H; Yamamoto M; Touge T; Deguchi K; Masaki T
    Mult Scler Relat Disord; 2019 Oct; 35():182-184. PubMed ID: 31398656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: Two paradigmatic cases and a review of the literature.
    Foiadelli T; Gastaldi M; Scaranzin S; Franciotta D; Savasta S
    Mult Scler Relat Disord; 2020 Jun; 41():102011. PubMed ID: 32163756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children.
    Hou C; Wu W; Tian Y; Zhang Y; Zhu H; Zeng Y; Peng B; Zheng K; Li X; Chen W
    Mult Scler Relat Disord; 2020 Jul; 42():102018. PubMed ID: 32234601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
    Peschl P; Bradl M; Höftberger R; Berger T; Reindl M
    Front Immunol; 2017; 8():529. PubMed ID: 28533781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping syndrome of anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein inflammatory demyelinating diseases: A distinct clinical entity?
    Chen W; Li Q; Wang T; Fan L; Gao L; Huang Z; Lin Y; Xue Q; Liu G; Su Y; Zhang Y
    Mult Scler Relat Disord; 2021 Jul; 52():103020. PubMed ID: 34034214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of anti-MOG CNS demyelination with concomitant mild anti-NMDAR encephalitis.
    Zhou J; Tan W; Tan SE; Hu J; Chen Z; Wang K
    J Neuroimmunol; 2018 Jul; 320():107-110. PubMed ID: 29661538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.
    Nan D; Zhang Y; Han J; Jin T
    Neurol Sci; 2021 Mar; 42(3):847-855. PubMed ID: 33409829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.